About bright minds biosciences inc - DRUG
Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in Chicago, IL.
DRUG At a Glance
Bright Minds Biosciences, Inc.
400 North Aberdeen Street
Chicago, Illinois 60642
| Phone | 1-647-407-2515 | Revenue | 0.00 | |
| Industry | Biotechnology | Net Income | -8,746,898.64 | |
| Sector | Health Technology | Employees | N/A | |
| Fiscal Year-end | 09 / 2026 | |||
| View SEC Filings |
DRUG Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | N/A |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | N/A |
DRUG Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | N/A |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
DRUG Liquidity
| Current Ratio | 36.101 |
| Quick Ratio | 36.101 |
| Cash Ratio | 35.501 |
DRUG Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -26.834 |
| Return on Equity | -27.74 |
| Return on Total Capital | -14.811 |
| Return on Invested Capital | -27.714 |
DRUG Capital Structure
| Total Debt to Total Equity | 0.153 |
| Total Debt to Total Capital | 0.153 |
| Total Debt to Total Assets | 0.149 |
| Long-Term Debt to Equity | 0.05 |
| Long-Term Debt to Total Capital | 0.05 |